• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雄激素非依赖性转移性前列腺癌中TMPRSS2-ETS基因畸变的特征分析

Characterization of TMPRSS2-ETS gene aberrations in androgen-independent metastatic prostate cancer.

作者信息

Mehra Rohit, Tomlins Scott A, Yu Jianjun, Cao Xuhong, Wang Lei, Menon Anjana, Rubin Mark A, Pienta Kenneth J, Shah Rajal B, Chinnaiyan Arul M

机构信息

Michigan Center for Translational Pathology, Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan, USA.

出版信息

Cancer Res. 2008 May 15;68(10):3584-90. doi: 10.1158/0008-5472.CAN-07-6154.

DOI:10.1158/0008-5472.CAN-07-6154
PMID:18483239
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2677168/
Abstract

Recurrent gene fusions between the androgen-regulated gene TMPRSS2 and the ETS transcription factor family members ERG, ETV1, and ETV4 have been identified as a critical event in prostate cancer development. In this study, we characterized the prevalence and diversity of these rearrangements in hormone-refractory metastatic prostate cancer. We used a fluorescence in situ hybridization (FISH) split probe strategy to comprehensively evaluate TMPRSS2-ETS aberrations across 97 nonosseous metastatic sites of prostate cancer from 30 rapid autopsies of men who died of androgen-independent disease. Tissue microarrays were constructed representing multiple metastatic sites from each patient, and split signal FISH probes for TMPRSS2, ERG, ETV1, and ETV4 were used to assess for TMPRSS2-ETS rearrangements. In patients exhibiting these aberrations, multiple sites from an individual case harbored the same gene fusion molecular subtype suggesting clonal expansion of disease. The most common prostate cancer gene fusion, TMPRSS2-ERG, can be generated by the mechanism of interstitial deletion (Edel) about 39% to 60% of the time in clinically localized disease. Interestingly, we observed that all of the androgen-independent metastatic prostate cancer sites harboring TMPRSS2-ERG were associated with Edel. These findings suggest that TMPRSS2-ERG with Edel is an aggressive and, in this study, uniformly lethal molecular subtype of prostate cancer associated with androgen-independent disease.

摘要

雄激素调节基因TMPRSS2与ETS转录因子家族成员ERG、ETV1和ETV4之间的复发性基因融合已被确定为前列腺癌发展中的关键事件。在本研究中,我们对激素难治性转移性前列腺癌中这些重排的发生率和多样性进行了特征分析。我们采用荧光原位杂交(FISH)分裂探针策略,对30例死于雄激素非依赖性疾病的男性快速尸检中97个非骨性前列腺癌转移部位的TMPRSS2-ETS畸变进行了全面评估。构建了代表每位患者多个转移部位的组织微阵列,并使用针对TMPRSS2、ERG、ETV1和ETV4的分裂信号FISH探针评估TMPRSS2-ETS重排。在表现出这些畸变的患者中,单个病例的多个部位具有相同的基因融合分子亚型,提示疾病的克隆性扩增。最常见的前列腺癌基因融合TMPRSS2-ERG,在临床局限性疾病中约39%至60%的情况下可通过间质缺失(Edel)机制产生。有趣的是,我们观察到所有携带TMPRSS2-ERG的雄激素非依赖性转移性前列腺癌部位均与Edel相关。这些发现表明,伴有Edel的TMPRSS2-ERG是一种侵袭性的、在本研究中一致致命的前列腺癌分子亚型,与雄激素非依赖性疾病相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e43e/2677168/4b81a0d7d61a/nihms104651f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e43e/2677168/17b3a7704fb2/nihms104651f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e43e/2677168/1ceb2c91f8a8/nihms104651f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e43e/2677168/4b81a0d7d61a/nihms104651f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e43e/2677168/17b3a7704fb2/nihms104651f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e43e/2677168/1ceb2c91f8a8/nihms104651f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e43e/2677168/4b81a0d7d61a/nihms104651f3.jpg

相似文献

1
Characterization of TMPRSS2-ETS gene aberrations in androgen-independent metastatic prostate cancer.雄激素非依赖性转移性前列腺癌中TMPRSS2-ETS基因畸变的特征分析
Cancer Res. 2008 May 15;68(10):3584-90. doi: 10.1158/0008-5472.CAN-07-6154.
2
Characterization of ETS gene aberrations in select histologic variants of prostate carcinoma.前列腺癌特定组织学变体中ETS基因畸变的特征分析。
Mod Pathol. 2009 Sep;22(9):1176-85. doi: 10.1038/modpathol.2009.79. Epub 2009 May 22.
3
Comprehensive assessment of TMPRSS2 and ETS family gene aberrations in clinically localized prostate cancer.临床局限性前列腺癌中TMPRSS2和ETS家族基因畸变的综合评估
Mod Pathol. 2007 May;20(5):538-44. doi: 10.1038/modpathol.3800769. Epub 2007 Mar 2.
4
TMPRSS2:ERG fusion by translocation or interstitial deletion is highly relevant in androgen-dependent prostate cancer, but is bypassed in late-stage androgen receptor-negative prostate cancer.通过易位或间质性缺失形成的TMPRSS2:ERG融合在雄激素依赖性前列腺癌中高度相关,但在晚期雄激素受体阴性前列腺癌中则不存在。
Cancer Res. 2006 Nov 15;66(22):10658-63. doi: 10.1158/0008-5472.CAN-06-1871.
5
TMPRSS2:ETS fusions and clinicopathologic characteristics of prostate cancer patients from Eastern China.中国东部前列腺癌患者的TMPRSS2:ETS融合与临床病理特征
Asian Pac J Cancer Prev. 2014;15(7):3099-103. doi: 10.7314/apjcp.2014.15.7.3099.
6
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.前列腺癌中TMPRSS2与ETS转录因子基因的反复融合
Science. 2005 Oct 28;310(5748):644-8. doi: 10.1126/science.1117679.
7
Gene fusions between TMPRSS2 and ETS family genes in prostate cancer: frequency and transcript variant analysis by RT-PCR and FISH on paraffin-embedded tissues.前列腺癌中TMPRSS2与ETS家族基因之间的基因融合:通过对石蜡包埋组织进行RT-PCR和FISH分析其频率及转录本变体
Mod Pathol. 2007 Sep;20(9):921-8. doi: 10.1038/modpathol.3800903. Epub 2007 Jul 13.
8
Noninvasive detection of TMPRSS2:ERG fusion transcripts in the urine of men with prostate cancer.前列腺癌男性尿液中TMPRSS2:ERG融合转录本的无创检测
Neoplasia. 2006 Oct;8(10):885-8. doi: 10.1593/neo.06625.
9
A fluorescence in situ hybridization screen for E26 transformation-specific aberrations: identification of DDX5-ETV4 fusion protein in prostate cancer.一项用于检测E26转化特异性畸变的荧光原位杂交筛查:前列腺癌中DDX5-ETV4融合蛋白的鉴定。
Cancer Res. 2008 Sep 15;68(18):7629-37. doi: 10.1158/0008-5472.CAN-08-2014.
10
TMPRSS2 fusions with oncogenic ETS factors in prostate cancer involve unbalanced genomic rearrangements and are associated with HDAC1 and epigenetic reprogramming.前列腺癌中TMPRSS2与致癌性ETS因子的融合涉及基因组重排失衡,并与HDAC1及表观遗传重编程相关。
Cancer Res. 2006 Nov 1;66(21):10242-6. doi: 10.1158/0008-5472.CAN-06-1986.

引用本文的文献

1
Framework for the Pathology Workup of Metastatic Castration-Resistant Prostate Cancer Biopsies.转移性去势抵抗性前列腺癌活检病理检查的框架
Clin Cancer Res. 2025 Feb 3;31(3):466-478. doi: 10.1158/1078-0432.CCR-24-2061.
2
Research autopsy programmes in oncology: shared experience from 14 centres across the world.研究肿瘤学尸检项目:来自全球 14 个中心的共享经验。
J Pathol. 2024 Jun;263(2):150-165. doi: 10.1002/path.6271. Epub 2024 Mar 29.
3
Acquired copy number variation in prostate tumours: a review of common somatic copy number alterations, how they are formed and their clinical utility.

本文引用的文献

1
Complex patterns of ETS gene alteration arise during cancer development in the human prostate.在人类前列腺癌发生发展过程中会出现复杂的ETS基因改变模式。
Oncogene. 2008 Mar 27;27(14):1993-2003. doi: 10.1038/sj.onc.1210843. Epub 2007 Oct 8.
2
Heterogeneity of TMPRSS2 gene rearrangements in multifocal prostate adenocarcinoma: molecular evidence for an independent group of diseases.多灶性前列腺腺癌中TMPRSS2基因重排的异质性:一组独立疾病的分子证据
Cancer Res. 2007 Sep 1;67(17):7991-5. doi: 10.1158/0008-5472.CAN-07-2043.
3
The evolving biology and treatment of prostate cancer.
前列腺肿瘤中的获得性拷贝数变异:常见体细胞拷贝数改变的综述、其形成方式及其临床应用
Br J Cancer. 2024 Feb;130(3):347-357. doi: 10.1038/s41416-023-02485-7. Epub 2023 Nov 9.
4
Loss of feedback regulation between FAM3B and androgen receptor driving prostate cancer progression.FAM3B 与雄激素受体之间反馈调节的丧失驱动前列腺癌的进展。
J Natl Cancer Inst. 2024 Mar 7;116(3):421-433. doi: 10.1093/jnci/djad215.
5
Development and characterization of an ETV1 rabbit monoclonal antibody for the immunohistochemical detection of ETV1 expression in cancer tissue specimens.一种用于检测癌症组织标本中 ETV1 表达的 ETV1 兔单克隆抗体的开发和鉴定。
J Immunol Methods. 2023 Jul;518:113493. doi: 10.1016/j.jim.2023.113493. Epub 2023 May 16.
6
Metastatic prostate cancer diagnosed by fine-needle aspiration: Contemporary cytopathologic and biomarker assessment with clinical correlates.经细针穿刺诊断的转移性前列腺癌:当代细胞病理学和生物标志物评估及其与临床的相关性。
Cancer Cytopathol. 2023 Feb;131(2):117-135. doi: 10.1002/cncy.22652. Epub 2022 Oct 20.
7
Giemsa-negative chromosome bands preferentially recombine in cancer-associated translocations and gene fusions.吉姆萨阴性染色体带优先在癌症相关易位和基因融合中发生重组。
Genes Chromosomes Cancer. 2023 Feb;62(2):61-74. doi: 10.1002/gcc.23095. Epub 2022 Sep 30.
8
Race and prostate cancer: genomic landscape.种族与前列腺癌:基因组景观。
Nat Rev Urol. 2022 Sep;19(9):547-561. doi: 10.1038/s41585-022-00622-0. Epub 2022 Aug 9.
9
The importance of personalized medicine in urological cancers.个性化医疗在泌尿生殖系统癌症中的重要性。
J Diabetes Metab Disord. 2021 Jun 29;21(1):841-852. doi: 10.1007/s40200-021-00824-0. eCollection 2022 Jun.
10
The evolving landscape of prostate cancer somatic mutations.前列腺癌体细胞突变的演进景观。
Prostate. 2022 Aug;82 Suppl 1(Suppl 1):S13-S24. doi: 10.1002/pros.24353.
前列腺癌不断发展的生物学特性与治疗方法
J Clin Invest. 2007 Sep;117(9):2351-61. doi: 10.1172/JCI31791.
4
Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer.不同类型的染色体重排会在前列腺癌中产生致癌性ETS基因融合。
Nature. 2007 Aug 2;448(7153):595-9. doi: 10.1038/nature06024.
5
Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer.TMPRSS2与ERG序列融合的重复可识别致命性人类前列腺癌。
Oncogene. 2008 Jan 10;27(3):253-63. doi: 10.1038/sj.onc.1210640. Epub 2007 Jul 16.
6
A variant TMPRSS2 isoform and ERG fusion product in prostate cancer with implications for molecular diagnosis.前列腺癌中一种变异的跨膜丝氨酸蛋白酶2(TMPRSS2)同工型与ERG融合产物及其对分子诊断的意义
Mod Pathol. 2007 Apr;20(4):467-73. doi: 10.1038/modpathol.3800759. Epub 2007 Mar 2.
7
Comprehensive assessment of TMPRSS2 and ETS family gene aberrations in clinically localized prostate cancer.临床局限性前列腺癌中TMPRSS2和ETS家族基因畸变的综合评估
Mod Pathol. 2007 May;20(5):538-44. doi: 10.1038/modpathol.3800769. Epub 2007 Mar 2.
8
Frequency of the TMPRSS2:ERG gene fusion is increased in moderate to poorly differentiated prostate cancers.TMPRSS2:ERG基因融合在中分化至低分化前列腺癌中的频率增加。
J Clin Pathol. 2007 Nov;60(11):1238-43. doi: 10.1136/jcp.2006.043810. Epub 2007 Jan 26.
9
TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort.TMPRSS2:ERG基因融合与观察等待队列中致命性前列腺癌相关。
Oncogene. 2007 Jul 5;26(31):4596-9. doi: 10.1038/sj.onc.1210237. Epub 2007 Jan 22.
10
Expression of TMPRSS2:ERG gene fusion in prostate cancer cells is an important prognostic factor for cancer progression.TMPRSS2:ERG基因融合在前列腺癌细胞中的表达是癌症进展的重要预后因素。
Cancer Biol Ther. 2007 Jan;6(1):40-5. doi: 10.4161/cbt.6.1.3489.